연구사례로 본 적응증확장

기도청결요법중 가장 효과적으로 알려진 고빈도흉벽진동요법은 활발한 연구를 통하여 적응증을 점차 넓혀가고 있습니다.

관련연구사례

  • 뇌졸증환자의 운동성 향상

    Effect of the High Frequency Chest Wall Oscillation (HFCWO) on Pulmonary Function and Walking Ability in Stroke Patients

    결론 : TT와 고빈도흉벽진동요법이 뇌졸증환자의 폐기능과 보행능력을 향상시킴

    Conclusion : The TT(threadmill training) and HFCWO effectively improved pulmonary function and walking ability in subjects with stroke. The proposed program can be applied to stroke patients as a useful therapy.

  • 만성폐쇄성폐질환(COPD_Chronic Obstructive Lung Disease)환자의 호흡기 기능 개선 및 폐 분비물 제거 능력의 향상

    OUTCOMES OF HIGH FREQUENCY CHEST WALL OSCILLATION (HFCWO) IN COPD PATIENTS WITHOUT BRONCHIECTASIS

    결론 : 본 연구는 기관지확장증이 없는 COPD환자의 입원 횟수, 호흡기의 건강, 폐분비물제거능력이 개선되었음을 입증하였으며, 이러한 개선효과는 최소 1년간 지속되었음을 보여줌

    Conclusion : This study shows that outcomes in COPD patients without bronchiectasis, as measured by number of hospitalizations, self-reported respiratory health, and the ability to clear secretions, improved substantially after the initiation of HFCWO therapy. These improvements were sustained for at least one year.

  • 고빈도흉벽진동요법을 통한 급성천식 또는 만성폐쇄성폐질환(COPD) 환자의 조기 치료 효과

    EARLY TREATMENT OF ACUTE ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) WITH HIGH FREQUENCY CHEST WALL OSCILLATION (HFCWO) IN HOSPITALIZED PATIENTS

    결론 : HFCWO치료는 급성천식또는 COPD로 입원한 성인환자에게 우수한 내약성과 호흡곤란증상을 우수하게 개선함을 증명

    Conclusion : Treatment with HFCWO is well tolerated in adults hospitalized for acute asthma or COPD and significantly improves dyspnea.

  • 천식 치료를 위한 고빈도흉벽진동요법의 타당성(적절성)

    Feasibility of High Frequency Chest Wall Oscillation (HFCWO) for Treatment of Asthma Exacerbations

    결론 : HFCWO는 천식질환자의 호흡곤란 문제를 개선할 수 있음을 증명

    Conclusion : HFCWO is feasible and may improve dyspnea during asthma exacerbations.

  • 가족성 자율신경실조증 환자에 대한 고빈도흉벽진동요법의 효과 평가

    Assessing Efficacy of High-Frequency Chest Wall Oscillation in Patients With Familial Dysautonomia

    결론 : FD 환자에 대한 이 제한된 연구에서 HFCWO는 측정된 모든 건강 결과와 산소포화도에 상당한 개선을 가져왔으며, FVC 및 PEFR은 폐 기능 측정을 통해 지속적인 개선효과를 확인

    Conclusion : With its commitment to FD, HFCWO is committed and FVC is committed to PEFR.

  • 신경계 장애 아동을 대한으로 한 고빈도흉벽진동요법의 효과

    High-Frequency Chest Wall Compression Therapy in Neurologically Impaired Children

    결론 : 정기적인 고빈도흉벽진동요법으로 신경계 장애 아동의 입원 횟수를 줄일 수 있음

    Conclusion : Regular HFCWC therapy may reduce the number of hospitalizations in neurologically impaired children.

  • 흉부 수술 환자에 대한 고빈도흉벽진동요법의 효과(48시간)

    High-Frequency Chest-Wall Compression During the 48 Hours Following Thoracic Surgery

    결론 : 흉부 수술 환자에 대한 고빈도흉벽진동요법의 안전성과 보조기구로서의 실효성 입증

    Conclusion : HFCWC is a safe, well-tolerated adjunct after thoracic surgery. The observation of hemodynamic stability is especially important, considering that the patients were studied in the early postoperative period, during epidural analgesia.

  • 중증 COPD환자를 대상으로 한 고빈도흉벽진동요법의 안전성과 효과에 관한 연구

    Safety and effectiveness of the high-frequency chest wall oscillation vs intrapulmonary percussive ventilation in patients with severe COPD

    결론 : 중증 COPD환자를 대한으로 한 고빈도흉벽진동요법이 환자들의 폐 기능 개선과 객담염증세포의 감소에 효과적

    Conclusion : The two techniques improved daily life activities and lung function in patients with severe COPD. IPV demonstrated a significantly greater effectiveness in improving some pulmonary function tests linked to the small bronchial airways obstruction and respiratory muscle strength and scores on health status assessment scales (BCSS and CAT) as well as a reduction of sputum inflammatory cells compared with HFCWO.

  • 기관지확장증환자들을 대상으로 한 고빈도흉벽진동요법의 효과

    Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis

    결론 : 고빈도흉벽진동요법은 만성과분비질환 환자의 폐 기능 개선과 더불어 환자의 삶의 질을 개선한다. 이러한 환자 군의 치료패턴을 고려하여 흉부 물리 치료의 주요옵션으로 포함되어야 함을 주장

    Conclusion : The HFCWO technique provides an improvement both in pulmonary function and quality of life related parameters in patients with chronic hypersecretive disease. Since those patients need daily airway clearance, this treatment should be included among the principal options in chest physiotherapy. The study was registered as ChiCTR-TRC-12002134 at.

  • 낭포성 섬유종 환자를 대상으로 한 고빈도흉벽진동요법의 단기적 효과에 관한 연구

    Short-Term Effects of High-Frequency Chest Compression and Positive Expiratory Pressure in Patients With Cystic Fibrosis

    결론 : 고빈도흉벽진동요법은 호기양압마스크와 유사한 효과가 있음을 입증

    Conclusion : High-frequency chest compression and positive expiratory pressure mask have comparable short-term effects on expectorated sputum and lung function. Although positive expiratory pressure mask was associated with a lower SpO2, it was better tolerated than high-frequency chest compression.

  • 고빈도흉벽진동요법의 신경근 질환 환자에 미치는 치료적 효과

    The Impact of High-Frequency Chest Wall Oscillation on Healthcare Use in Patients with Neuromuscular Diseases

    결론 : 광범위한 신경근 질환 환자들에게 고빈도흉벽진동요법을 통하여 의료비용, 입원 및 폐렴 치료 비용의 절감을 확인. 흉벽진동요법이 환자들의 더 나은 수준의 치료 지표가 될 수 있다는 점을 연구

    Conclusion : Total medical costs, hospitalizations, and pneumonia claims were less after than before initiation of HFCWO in a broad group of patients with neuromuscular disease. Subject to the limitations that administrative data did not capture how HFCWO was used and that HFCWO may be a marker of generally better care, our findings lend support to the routine use of this intervention in the care of patients with neuromuscular diseases.

  • 코로나환자를 대상으로 한 고빈도흉벽진동요법의 효과(예비타당성 연구)

    High-Frequency Chest Wall Oscillation in Patients with COVID-19: A Pilot Feasibility Study

    결론 : 초기 코로나환자의 폐 재활치료에 고빈도흉벽진동요법을 적용한 결과 상당한 개선이 PFT에서 발견되었고 산소포화도의 향상을 가져옴

    Conclusion : This study demonstrated that pulmonary rehabilitation applied with the HFCWO device in patients with COVID-19 in the early period contributed to the improvement of oxygenation by providing significant improvement as observed in the PFTs of the patients.

  • 고빈도흉벽진동요업을 이용한 마이코플라즈마 환아의 폐렴 증상 개선

    The Efficacy of High-frequency Chest Wall Oscillation (HFCWO) for the Improvement of Symptoms in Children with Mycop asma pneumonia

    결론 : 고빈도흉벽진동요법 보조치료가 마이코플라즈마 환아의 폐렴 증상 개선에 효과적이고 입원 기간을 단축하며 치료 비용의 절감에 효과적

    Conclusion : Our findings demonstrate that combination of adjuvant treatmentwith HFCWO may help children withM. pneumoniae pneumonia to achieve clear improvements in clinical symptoms, reduce the length of hospital stays, and reduce costs. Further studies, incorporating multiple centers, are now needed to evaluate clinical efficacy, tolerability, adverse effects, and cost effectiveness.